Consultant Endocrinologist

Dr. Mounam Chattopadhyay

Personal Info

Working as Senior Resident in Department of Endocrinology, Nilratan Sircar Medical College & Hospital, Kolkata, from 15.09.2022 till date

  • Worked as Observer in the Department of Molecular Genetics and Cytogenetics at Tata Medical Center, 14 MAR, DH Block(Newtown), Action Area I, Newtown, Kolkata, Chakpachuria, West Bengal 700160 from 16.05.2022 to 30.05.2022
  • Worked as researcher in collaboration with Department of Psychiatry, Institute of Neurosciences, Kolkata, Rehabilitation, Research and Psychiatric Center, 10, West Range, Kolkata-700017 in 2020 to study the psychomotor functions in patients of Turner Syndrome.
  • Teaching in UG and paramedical courses in different Medical Colleges in Kolkata
  • Worked as Senior Resident in Department of General Medicine CNMC&H, Kolkata from 01.07.2019- 24.08.2019
  • Post-MBBS Internship (2015-16) from NRS Medical College, Kolkata, WBUHS
  •  

Academic & Institutional Appointment/Affiliations

  • Visiting Consultant Endocrinologist at Calcutta Heart Clinic & Hospital, HC 4, 1st Cross Rd, HC Block, Sector 3, Bidhannagar, Kolkata, West Bengal 700106
  • Visiting Consultant Endocrinologist at Kasturi Medical Centre, Diamond Harbour Road, Joka Kolkata, West Bengal 700104
  • Visiting Consultant Endocrinologist at Techno India DAMA Healthcare & Medical Centre, LB 10, Eastern Metropolitan Bypass Rd, Chingrighata, LB Block, Sector 3, Bidhannagar, Kolkata, West Bengal 700106
  • Visiting Consultant Endocrinologist at Apollo Clinics, Newtown, Beliaghata, Howrah
  • Senior Resident at Dept. Of Endocrinology – Nilratan Sircar Medical College & Hospital, Kolkata
  • Former Senior Resident at Dept. Of Medicine – Calcutta National Medical College & Hospital, Kolkata
Specially :

Consultant Endocrinologist

Degrees :

MBBS (Hons.) (2010-15) | MD (Internal Medicine) (2016-19) | MRCP UK I & II, 2021 | DM (Endocrinology) (2019-22) | DrNB Endocrinology Part 1 Examination 2022

Experience :

Over 11 years of experience in the specialization

Membership

  • Endocrine Society of India (ESI)
  • Association of Physicians of India (API)
  • Research Society for the study of Diabetes in India (RSSDI)
  • Indian Society for Bone and mineral research (ISBMR|)

Publications

  • Chattopadhyay M, Sahana PK, Sengupta N, Goswami S, Baidya A. GONADS: Clinical and Hormonal Profile Of Turner Syndrome with relation to karyotype in a tertiary care center in eastern India. Indian J Endocrinol Metab. 2020 Sep-Oct; 24(5): 452–505. PMCID: PMC7810050. 
  • Chattopadhyay M, Goswami S, Sahana PK, Baidya A, Sengupta N, Banerjee A, Yashaswi. DIABETES: When insulin hits too hard; though with a different hammer. . Indian J Endocrinol Metab. 2020 Sep-Oct; 24(5): 452–505. PMCID: PMC7810050. 
  • Goswami S, Chattopadhyay M. Comparative Analysis of Major Cholesterol Guidelines. In: Ghosh S, Saboo B. (eds.) Manual of Lipidology. New Delhi, India: Jaypee Brothers Medical Publishers (P) Ltd; January, 2021. p.211-227.
  • Chattopadhyay M, Sahana PK. A Tale of Discovery of Insulin. In: Insulin Discovery: The First Centenary Celebration Symposium. Kolkata, India: Diabetic Association of India, West Bengal; July 30, 2021. p.4-7. Available from: https://daiwb.in/wp-content/uploads/2021/07/Souvenir_IDD-2021-compressed.pdf [Accessed 31st July 2021]
  • Goswami S, Chattopadhyay M. Lipid Profile: A Review of its Basics. International Journal of Atherogenic Diabetic Dyslipidemia.2021; 
  • Sahana PK, Chattopadhyay M. Pseudo-Cushing Syndrome [Internet]. ClinicalKey Now; 2022 May 19 [cited June 6]. Available from: https://www.clinicalkey.com/now/in/content/76-s2.0-in_en_pseudo_cushing_syndrome#hl0000273
  • Baidya A, Pathak Y, Sengupta N, Sahana PK, Goswami S, Tarenia S, Banerjee A, Chattopadhayay M, Hathi D, Gaikwad PM, Das N; 158-LB: Effect of Vitamin D Replacement on Glycemic Status and Pregnancy Outcomes in Vitamin D–Deficient Subjects with Gestational Diabetes Mellitus. Diabetes 1 June 2022; 71 (Supplement_1): 158–LB. https://doi.org/10.2337/db22-158-LB
  • Goswami S, Chattopadhyay M. A mini-review in thyroid function test: more than meets our eye. Avicenna J Med Biochem. 2023; 11(1):88-91. doi:10.34172/ajmb.2023.2420. (3/5/23)
  • Banerjee A, Chattopadhyay M. Polyglandular Autoimmune Syndrome [Internet]. ClinicalKey Now; 2023 August 25. Available from: https://www.clinicalkey.com/now/in/content/80-s2.0-in_en_polyglandular_autoimmune_syndrome
  • Chattopadhyay, M., Mukherjee , A., & Sahana, P. (2025). Clinical and Genotypic Insights into Turner Syndrome: Emphasis on Cardiovascular Abnormalities. Journal of the ASEAN Federation of Endocrine Societies. https://doi.org/10.15605/jafes.040.02.24
  • Chawla R, T K S, Singh K, et al. (N/A) Real-world assessment of dapagliflozin-based therapies in patients with type 2 diabetes mellitus in an outpatient setting across India: Dapaturn study. Cureus (): e. doi:10.7759/cureus.

Research/Clinical Trial/Presentation

  • Presented an e-poster titled “A peculiar case of disproportionate short stature with diabetes in young” in ENDO UPDATE 2020 virtual conference organized in association with Osmania Medical College, Hyderabad. [20.09.2020]
  • Presented another e-poster titled “When the parathormone gets dry but the bones cry and die” at the national virtual conference of Indian Society of Bone Mineral and Research. [01.11.2020]
  • Presented another e-poster titled “Clinical and Hormonal Profile Of Turner Syndrome with relation to karyotype in a tertiary care center in eastern India” and declared the winner in the “Pituitary and Gonads” session at Endocrine Week 2020 Virtual Conference organized by Endocrine Society of India. [17.11.2020]
  • Presented another e-poster titled “When insulin hits too hard; though with a different hammer” in the “Diabetes, Obesity and Metabolism” session at Endocrine Week 2020 Virtual Conference organized by Endocrine Society of India. [18.11.2020]
  • Presented a case of ‘Diabetic Foot’ (Clinical Case 4) in Digital Endocrine Enrichment Programme 2021-22 5th edition on 09.01.2022.
  • Participated in ESI-TYSA 2022 05.02.2022-06.02.2022 Preliminary Round and cleared Level 1.
  • Presented a research paper on “A study on clinical and biochemical profile of Turner syndrome with special reference to cardiovascular abnormalities” at CRESCENDO 2022 on 29.04.2022.
  • Drawing selected for back inner cover page of ESI Yearbook 2022 in the Cover Page Design Contest based on the theme: Indian Endocrinology in Global Scenario. [26.5.2022]
  • Participated as Faculty in Train the Trainer activity titled “Synergy in Diabetes Management-A Clinical Update Series” conducted in India in the year 2023 organised by Endocrine Society, 2055 L Street NW, Suite 600, Washington, DC 20036

Awards & Achievements

  • Secured university second position in WBUHS DM Endocrinology final exit examination 2022
  • Gold medal winner in WBUHS MD Medicine final exit examination 2019
  • Prof Sital Ghosh Memorial Gold Medal Winner for academic proficiency in Medicine in 2019
  • Gold Medal Winner for academic proficiency in UG course (MBBS) in 2015 in NRS Medical College
  • Gold Medal Winner for academic proficiency in ENT in 2014 in NRS Medical College
  • Selected as Senior Class Assistant in Physiology in 2010 in NRS Medical College
  • Secured 10th position in Higher Secondary Examination in WB in 2010
  • Secured 8th position Secondary Examination (Madhyamik Pariksha) in WB in 2008

Oral Presentations / Other Speaking Engagements

  • Speaker on “ Optimizing outcomes Tailoring Sitagliptin combinations for individualized Diabetes care with or without co – morbid conditions “ – Dr. Reddy’s
  • Speaker on “ Glucose Control & CareMe Prevention “ – AstraZeneca
  • Speaker on “ How to Differentiate patient profile of DAPA + LINA from DAPA + LINA + MET ? “ – Torrent
  • Speaker on “ Finerenone – a new hope for cardio – renal outcome in pt with T2D & CKD “- Bayer
  • Speaker on “ Expert exchange begin with Gla-100, sustain with Optimal Basal supported Oral therapy “ – Sanofi
  • Speaker on “ Management of HTN in pt with T2DM “ – JB
  • Speaker on “ First Move – changing the game with IDEGASP” – Novo Nordisk
  • Speaker on “ Thyroid Future Roadmap “ – Merck
  • Speaker on “ Patients Counseling Strategies on Insulin “ – Mankind
  • Speaker on “ Vildagliptin – the right add on therapy in T2D “ – Cipla

Send a message